[Pubmed] Corrigendum to "Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia grav
Posté : 09 févr. 2025 12:00
J Neuroimmunol. 2025 Jan 16:578526. doi: 10.1016/j.jneuroim.2025.578526. Online ahead of print.
NO ABSTRACT
PMID:39924423 | DOI:10.1016/j.jneuroim.2025.578526
Source: https://pubmed.ncbi.nlm.nih.gov/3992442 ... t9+e462414